Rubius Therapeutics (RUBY) Short Interest Ratio & Short Volume → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Free RUBY Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisInsider TradesSocial MediaSustainabilityStock AnalysisInsider TradesSocial MediaSustainability Rubius Therapeutics Short Interest DataCurrent Short Volume2,800,000 sharesPrevious Short Volume1,530,000 sharesChange Vs. Previous Month+83.01%Dollar Volume Sold Short$408,520.00Short Interest Ratio / Days to Cover0.7Last Record DateFebruary 28, 2023Outstanding Shares90,480,000 sharesFloat Size45,880,000 sharesShort Percent of Float6.10%Today's Trading Volume755,858 sharesAverage Trading Volume1,154,788 sharesToday's Volume Vs. Average65% Short Selling Rubius Therapeutics ? Sign up to receive the latest short interest report for Rubius Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRUBY Short Interest Over TimeRUBY Days to Cover Over TimeRUBY Percentage of Float Shorted Over Time Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Rubius Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/20232,800,000 shares $408,520.00 +83.0%6.1%0.7 $0.15 2/15/20231,530,000 shares $257,040.00 -18.2%3.3%0.6 $0.17 1/31/20231,870,000 shares $487,135.00 -24.6%4.1%1.4 $0.26 1/15/20232,480,000 shares $730,856.00 +21.6%5.5%2 $0.29 12/30/20222,040,000 shares $357,000.00 +13.3%4.5%1.8 $0.18 12/15/20221,800,000 shares $324,180.00 +5.9%4.0%2.4 $0.18 Get the Latest News and Ratings for RUBY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rubius Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/20221,700,000 shares $377,400.00 -9.1%3.7%1 $0.22 11/15/20221,870,000 shares $527,714.00 -14.2%4.1%0.5 $0.28 10/31/20222,180,000 shares $739,020.00 -18.4%4.8%0.6 $0.34 10/15/20222,670,000 shares $1.05 million -10.7%5.9%0.8 $0.40 9/30/20222,990,000 shares $1.30 million +19.1%6.6%0.9 $0.43 9/15/20222,510,000 shares $1.74 million +4.2%5.5%0.7 $0.69 8/31/20222,410,000 shares $1.69 million -31.5%5.3%0.9 $0.70 8/15/20223,520,000 shares $2.85 million -6.6%7.7%5 $0.81 7/31/20223,770,000 shares $2.65 million -2.1%8.3%4.7 $0.70 7/15/20223,850,000 shares $3.21 million -2.8%8.5%3.6 $0.84 6/30/20223,960,000 shares $3.37 million -28.0%8.7%2.6 $0.85 6/15/20225,500,000 shares $4.62 million -8.5%12.1%3.5 $0.84 5/31/20226,010,000 shares $6.61 million -5.2%13.2%3.7 $1.10 5/15/20226,340,000 shares $8.24 million -9.4%13.9%4.2 $1.30 4/30/20227,000,000 shares $11.62 million -4.2%15.4%4.9 $1.66 4/15/20227,310,000 shares $14.55 million -20.6%16.2%5.2 $1.99 3/31/20229,210,000 shares $50.75 million -6.0%20.4%10.3 $5.51 3/15/20229,800,000 shares $53.61 million -10.7%21.7%13.8 $5.47 2/28/202210,970,000 shares $54.74 million +3.6%24.3%18.2 $4.99 2/15/202210,590,000 shares $61.00 million +12.9%23.5%18.7 $5.76 1/31/20229,380,000 shares $63.32 million +14.4%20.7%18.1 $6.75 1/15/20228,200,000 shares $72.32 million -10.7%18.1%18.1 $8.82 12/31/20219,180,000 shares $88.86 million +4.2%N/A23.3 $9.68 12/15/20218,810,000 shares $116.38 million +20.0%19.4%23 $13.21 11/30/20217,340,000 shares $90.72 million -5.1%16.2%23 $12.36 11/15/20217,730,000 shares $104.20 million +7.1%17.1%25.6 $13.48 10/29/20217,220,000 shares $102.60 million -0.8%16.0%22.9 $14.21 10/15/20217,280,000 shares $118.52 million -1.8%16.1%24.2 $16.28 9/30/20217,410,000 shares $132.49 million +0.7%16.4%23.7 $17.88 9/15/20217,360,000 shares $147.20 million +1.1%16.3%20.4 $20.00 8/31/20217,280,000 shares $158.12 million +9.2%16.1%17.2 $21.72 8/13/20216,670,000 shares $163.42 million No Change14.8%14.3 $24.50 7/30/20216,670,000 shares $143.34 million +3.3%14.9%13.6 $21.49 7/15/20216,460,000 shares $147.87 million -2.4%14.4%12.2 $22.89SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. RUBY Short Interest - Frequently Asked Questions What is Rubius Therapeutics' current short interest? Short interest is the volume of Rubius Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 28th, investors have sold 2,800,000 shares of RUBY short. 6.10% of Rubius Therapeutics' shares are currently sold short. Learn More on Rubius Therapeutics' current short interest. What is a good short interest ratio for Rubius Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RUBY shares currently have a short interest ratio of 1.0. Learn More on Rubius Therapeutics's short interest ratio. What is a good short interest percentage for Rubius Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.10% of Rubius Therapeutics' floating shares are currently sold short. Is Rubius Therapeutics' short interest increasing or decreasing? Rubius Therapeutics saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 2,800,000 shares, an increase of 83.0% from the previous total of 1,530,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Rubius Therapeutics' float size? Rubius Therapeutics currently has issued a total of 90,480,000 shares. Some of Rubius Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Rubius Therapeutics currently has a public float of 45,880,000 shares. How does Rubius Therapeutics' short interest compare to its competitors? 6.10% of Rubius Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Rubius Therapeutics: Palisade Bio, Inc. (0.21%), Finch Therapeutics Group, Inc. (1.70%), Fresh Tracks Therapeutics, Inc. (0.17%), TRACON Pharmaceuticals, Inc. (32.67%), Titan Pharmaceuticals, Inc. (0.59%), Avalon GloboCare Corp. (1.74%), Creative Medical Technology Holdings, Inc. (2.17%), Gamida Cell Ltd. (7.11%), Windtree Therapeutics, Inc. (0.54%), BioCardia, Inc. (1.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Suncor Energy Inc. ($3.27 billion), Occidental Petroleum Co. ($2.77 billion), Coinbase Global, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.23 billion), Paramount Global ($1.92 billion), Etsy, Inc. ($1.75 billion), Voya Financial, Inc. ($1.74 billion), CarMax, Inc. ($1.62 billion), Old Dominion Freight Line, Inc. ($1.62 billion), and Royal Caribbean Cruises Ltd. ($1.39 billion). View all of the most shorted stocks. What does it mean to sell short Rubius Therapeutics stock? Short selling RUBY is an investing strategy that aims to generate trading profit from Rubius Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rubius Therapeutics? A short squeeze for Rubius Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RUBY, which in turn drives the price of the stock up even further. How often is Rubius Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RUBY, twice per month. The most recent reporting period available is February, 28 2023. More Short Interest Resources from MarketBeat Related Companies: PALI Short Interest Data FNCH Short Interest Data FRTX Short Interest Data TCON Short Interest Data TTNP Short Interest Data ALBT Short Interest Data CELZ Short Interest Data GMDA Short Interest Data WINT Short Interest Data BCDA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RUBY) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals